{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:30:51Z","timestamp":1788345051962,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.contraception.2010.03.020","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T08:07:37Z","timestamp":1274083657000},"page":"457-470","source":"Crossref","is-referenced-by-count":72,"title":["Clinical trials in male hormonal contraception"],"prefix":"10.1016","volume":"82","author":[{"given":"Eberhard","family":"Nieschlag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.03.020_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13625180601012311","article-title":"Contraception: a social revolution","volume":"12","author":"Benagiano","year":"2007","journal-title":"Europ Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.03.020_bib2","first-page":"194","article-title":"Disorders at the testicular level","author":"Nieschlag","year":"2009"},{"key":"10.1016\/j.contraception.2010.03.020_bib3","first-page":"304","article-title":"Wie effektiv sch\u00fctzen Kondome vor einer HIV-\u00dcbertragung?","volume":"88","author":"April","year":"1993","journal-title":"Med Klinik"},{"key":"10.1016\/j.contraception.2010.03.020_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tips.2003.11.009","article-title":"Progress towards hormonal male contraception","volume":"25","author":"Kamischke","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.contraception.2010.03.020_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men","volume":"336","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.03.020_bib6","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1210\/jc.80.8.2394","article-title":"Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders","volume":"80","author":"Behre","year":"1995","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/jc.75.5.1326","article-title":"Suppression of human spermatogenesis by testosterone implants","volume":"75","author":"Handelsman","year":"1992","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib8","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.81.11.4113","article-title":"Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot","volume":"81","author":"Handelsman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib9","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/jc.81.8.3018","article-title":"A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive","volume":"81","author":"Meriggiola","year":"1996","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jc.81.2.757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men","volume":"65","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib12","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1210\/jc.84.10.3642","article-title":"A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.01024.x","article-title":"Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.contraception.2010.03.020_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jc.87.2.546","article-title":"Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones and germ cell populations in normal young men","volume":"87","author":"McLachlan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib15","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1210\/jc.2002-022043","article-title":"International Committee for Contraception Research, The Population Council. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men","volume":"88","author":"von Eckardstein","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","article-title":"A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men","volume":"88","author":"Gu","year":"2003","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2008-1846","article-title":"Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men","volume":"94","author":"Gu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0010-7824(77)80002-4","article-title":"Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate","volume":"15","author":"Alvarez-Sanchez","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0010-7824(77)80005-X","article-title":"Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive","volume":"15","author":"Brenner","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0010-7824(77)80004-8","article-title":"The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose","volume":"15","author":"Frick","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0010-7824(77)80001-2","article-title":"Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate","volume":"15","author":"Melo","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2605.1981.tb00707.x","article-title":"Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg)","volume":"4","author":"Faundes","year":"1981","journal-title":"Int J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2605.1982.tb00253.x","article-title":"Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate","volume":"5","author":"Frick","year":"1982","journal-title":"Int J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0015-0282(16)56411-5","article-title":"Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men","volume":"60","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0015-0282(16)60735-5","article-title":"Combination of 19-nortestosterone-hexyoxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception","volume":"51","author":"Knuth","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(16)60623-4","article-title":"Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception","volume":"51","author":"Wu","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2605.1991.tb01089.x","article-title":"Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men","volume":"14","author":"Pangkahila","year":"1991","journal-title":"Int J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib28","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","article-title":"Contraceptive efficacy of a depot progestin and androgen combination in men","volume":"88","author":"Turner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib29","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men","volume":"89","author":"Gu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib30","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1210\/jc.2006-1411","article-title":"Testosterone gel combined with depo-medroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist","volume":"91","author":"Page","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/acta.0.0950251","article-title":"Clinical trial with levonorgestrel and testosterone enanthate for male fertility control","volume":"95","author":"Fogh","year":"1980","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2010.03.020_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotrophin levels with fewer metabolic effects than higher dosage combinations","volume":"20","author":"Anawalt","year":"1999","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib33","first-page":"98","article-title":"Inhibiting effects of Sino-implant plus testosterone undecanoate on spermatogenesis in Chinese men","volume":"10","author":"Ersheng","year":"1999","journal-title":"Reprod Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib34","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jc.87.8.3562","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone","volume":"87","author":"Gaw Gonzalo","year":"2002","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2605.2001.00319.x","article-title":"Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception","volume":"24","author":"P\u00f6ll\u00e4nen","year":"2001","journal-title":"Int J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/j.1939-4640.2004.tb02846.x","article-title":"Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in Chinese men","volume":"25","author":"Gui","year":"2004","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2164\/jandrol.04135","article-title":"Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial","volume":"26","author":"Anawalt","year":"2005","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2005-1743","article-title":"Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men","volume":"91","author":"Wang","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib39","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/jc.2007-0367","article-title":"Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis","volume":"92","author":"Wang","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/jc.86.1.303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception","volume":"86","author":"Kamischke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jc.87.2.530","article-title":"An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations","volume":"87","author":"Kamischke","year":"2002","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib42","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate","volume":"90","author":"Meriggiola","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2164\/jandrol.106.000281","article-title":"Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men","volume":"27","author":"Qoubaitary","year":"2006","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib44","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/13.5.1225","article-title":"Low dose of cyproterone acetate and testosterone enanthate for contraception in men","volume":"13","author":"Meriggiola","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/j.1939-4640.2002.tb02311.x","article-title":"Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen","volume":"23","author":"Meriggiola","year":"2002","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib46","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1210\/jc.2003-030574","article-title":"Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men","volume":"88","author":"Meriggiola","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1210\/jc.84.1.112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism","volume":"84","author":"Wu","year":"1999","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(00)01490-4","article-title":"Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression","volume":"74","author":"Anawalt","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1939-4640.2001.tb02157.x","article-title":"Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride","volume":"22","author":"Kinniburgh","year":"2001","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib50","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/17.11.2869","article-title":"Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone","volume":"17","author":"Anderson","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib51","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jc.87.8.3640","article-title":"Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception","volume":"87","author":"Anderson","year":"2002","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib52","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/17.6.1490","article-title":"Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men","volume":"17","author":"Kinniburgh","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib53","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/humrep\/deh491","article-title":"Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception","volume":"19","author":"Brady","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2164\/jandrol.107.002683","article-title":"7\u03b1-Methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men","volume":"28","author":"Walton","year":"2007","journal-title":"J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib55","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study","volume":"93","author":"Mommers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib56","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0010-7824(78)90045-8","article-title":"Clinical trial with testosterone undecanoate for male fertility control","volume":"18","author":"Nieschlag","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2605.1988.tb00994.x","article-title":"Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens","volume":"11","author":"Guerin","year":"1988","journal-title":"Int J Androl"},{"key":"10.1016\/j.contraception.2010.03.020_bib58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(97)00363-4","article-title":"An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men","volume":"68","author":"Meriggiola","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib59","article-title":"A new male contraceptive pill\/patch combination-oral desogestrel and transdermal testosterone: suppression of gonadotropins and spermatogenesis in men","author":"Hair","year":"1999"},{"key":"10.1016\/j.contraception.2010.03.020_bib60","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1210\/jc.84.4.1244","article-title":"Clinical trial of a transdermal testosterone and oral levonorgestrel for male contraception","volume":"84","author":"B\u00fcchter","year":"1999","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib61","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Hormonal Male Contraception Summit Group. Rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.03.020_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.contraception.2005.06.070","article-title":"Fertility control in wildlife: humans as a model","volume":"73","author":"Barfield","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3181\/00379727-40-10527P","article-title":"Production of oligospermia in a man by the use of testosterone propionate","volume":"40","author":"Heckel","year":"1939","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.contraception.2010.03.020_bib64","doi-asserted-by":"crossref","first-page":"-1","DOI":"10.1016\/S0015-0282(03)00577-6","article-title":"Development of methods of male contraception: impact of the World Health Organization Task Force","volume":"80","author":"Waites","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib65","first-page":"405","article-title":"Pharmacology of testosterone preparations","author":"Behre","year":"2004"},{"key":"10.1016\/j.contraception.2010.03.020_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.2006.02618.x","article-title":"Testosterone treatment comes of age: new options for hypogonadal men","volume":"65","author":"Nieschlag","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.contraception.2010.03.020_bib67","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.contraception.2005.10.012","article-title":"The acceptability of an injectable, once-a-month male contraceptive in China","volume":"73","author":"Zhang","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0010-7824(00)00139-6","article-title":"Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male contraception","volume":"62","author":"McLachlan","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib69","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0015-0282(16)49043-6","article-title":"Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation","volume":"44","author":"Knuth","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jc.74.1.84","article-title":"Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception","volume":"74","author":"Behre","year":"1992","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib71","first-page":"685","article-title":"Hormonal male contraception: the essential role of testosterone","author":"Nieschlag","year":"2004"},{"key":"10.1016\/j.contraception.2010.03.020_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2007-0041","article-title":"Advances in male contraception","volume":"29","author":"Page","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2010.03.020_bib73","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1210\/jc.83.10.3527","article-title":"Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone","volume":"83","author":"Swerdloff","year":"1998","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.contraception.2010.03.020_bib74","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/humrep\/16.12.2570","article-title":"Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by 19-nortestosterone alone in normal men","volume":"16","author":"Behre","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib75","first-page":"004316","article-title":"Steroid hormones for contraception in men (review)","author":"Grimes","year":"2007","journal-title":"Cochrane Database Syst Rec"},{"key":"10.1016\/j.contraception.2010.03.020_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","article-title":"Pregnancies associated with sperm concentrations below 10 million\/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters","volume":"20","author":"Barfield","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib77","author":"WHO"},{"key":"10.1016\/j.contraception.2010.03.020_bib78","first-page":"3","article-title":"Progress towards a male pill","volume":"31","author":"Anderson","year":"1997","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.contraception.2010.03.020_bib79","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/humrep\/15.3.637","article-title":"Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations","volume":"15","author":"Martin","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib80","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/humrep\/deh574","article-title":"Attitudes toward male fertility control: results of a multinational survey on four continents","volume":"20","author":"Heinemann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib81","series-title":"Development and Reproductive Health. Return of the population growth factor: its impact upon the Millennium Development Goals","year":"2007"},{"key":"10.1016\/j.contraception.2010.03.020_bib82","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.fertnstert.2006.11.003","article-title":"The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time?","volume":"87","author":"Strauss","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.020_bib83","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.contraception.2008.04.117","article-title":"Male fertility control \u2014 where are the men?","volume":"78","author":"Darroch","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.020_bib84","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/humrep\/del094","article-title":"Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men","volume":"21","author":"Meriggiola","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.03.020_bib85","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2006.12.001","article-title":"10th Summit Meeting Group. 10th Summit Meeting consensus recommendations for regulatory approval for hormonal male contraception, October 22-23, 2006","volume":"75","author":"Nieschlag","year":"2007","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241000137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241000137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:29:49Z","timestamp":1711484989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241000137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S001078241000137X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.03.020","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}